Beximco Pharmaceuticals Limited (AIM: BXP)
London flag London · Delayed Price · Currency is GBP · Price in GBX
21.50
0.00 (0.00%)
Sep 11, 2024, 4:14 PM GMT+1

Beximco Pharmaceuticals Cash Flow Statement

Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Mar '24 Jun '23 Jun '22 Jun '21 Jun '20 Jun '19 2018 - 2014
Net Income
5,3304,6145,1235,1283,5153,033
Upgrade
Depreciation & Amortization
1,7981,8481,6671,1141,114942.76
Upgrade
Other Amortization
27.5327.53----
Upgrade
Loss (Gain) From Sale of Assets
-18.07-13.82-12.62-3.9633.8-1.44
Upgrade
Asset Writedown & Restructuring Costs
184.5184.5----
Upgrade
Loss (Gain) on Equity Investments
-----29.33
Upgrade
Other Operating Activities
-137.6158.2346.0960.3322.43669.5
Upgrade
Change in Accounts Receivable
-632.66-431.84352.25431.6129.51-573.45
Upgrade
Change in Inventory
255.63-1,829-2,565-1,084-70.14-927.4
Upgrade
Change in Accounts Payable
1,0741,060-9.72587.17371100.1
Upgrade
Change in Income Taxes
327.48323.65-156.05-63.38154.27-269.23
Upgrade
Change in Other Net Operating Assets
163.76143.36469.16-146.0672.98-43.66
Upgrade
Operating Cash Flow
8,3736,0855,2146,0235,5422,960
Upgrade
Operating Cash Flow Growth
50.55%16.70%-13.43%8.67%87.25%62.71%
Upgrade
Capital Expenditures
-2,036-2,411-2,815-2,521-2,244-4,416
Upgrade
Sale of Property, Plant & Equipment
26.1223.3524.0632.833.6517.54
Upgrade
Cash Acquisitions
---4,767---
Upgrade
Sale (Purchase) of Intangibles
-375.14-231.54-124.29-37.73-31.75-128.62
Upgrade
Investment in Securities
-200---323.3616.03
Upgrade
Other Investing Activities
1.651.932.020.941.431.49
Upgrade
Investing Cash Flow
-2,583-2,617-7,680-2,525-1,947-4,510
Upgrade
Short-Term Debt Issued
--1,508--3,684
Upgrade
Long-Term Debt Issued
--2,731---
Upgrade
Total Debt Issued
-80.69-4,238--3,684
Upgrade
Short-Term Debt Repaid
--229.38--2,375-1,971-
Upgrade
Long-Term Debt Repaid
--1,763--504.64-1,000-1,412
Upgrade
Total Debt Repaid
-3,996-1,993--2,880-2,971-1,412
Upgrade
Net Debt Issued (Repaid)
-4,077-1,9934,238-2,880-2,9712,272
Upgrade
Common Dividends Paid
-1,583-1,568-1,623-578.35-601.96-505.35
Upgrade
Other Financing Activities
-----0
Upgrade
Financing Cash Flow
-5,660-3,5612,615-3,458-3,5731,767
Upgrade
Foreign Exchange Rate Adjustments
46.3859.8145.36-1.970.22
Upgrade
Net Cash Flow
176.62-32.99194.7140.4524.52216.76
Upgrade
Free Cash Flow
6,3373,6742,3993,5033,299-1,457
Upgrade
Free Cash Flow Growth
124.13%53.15%-31.51%6.17%--
Upgrade
Free Cash Flow Margin
14.71%9.36%6.92%11.88%12.88%-6.38%
Upgrade
Free Cash Flow Per Share
14.218.245.387.857.39-3.26
Upgrade
Cash Interest Paid
1,1651,2721,002861.451,0131,032
Upgrade
Cash Income Tax Paid
1,4681,1451,3471,450932.41,073
Upgrade
Levered Free Cash Flow
4,4241,724-1,0041,7992,160-2,915
Upgrade
Unlevered Free Cash Flow
5,1352,500-425.732,3032,775-2,282
Upgrade
Change in Net Working Capital
-873.11,0473,266219.48-577.51,722
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.